Navigation Links
Susan Lark, MD Urges Women to Fight for Their Right to Use Bioidentical Hormones
Date:1/3/2009

Susan Lark, MD, noted medical researcher and women's health practitioner, is urging women to continue waging a battle against the Food and Drug Administration's (FDA) steps to limit their access to bioidentical hormones.

Potomac, MD (PRWEB) January 2, 2009 -- Susan Lark, MD, noted medical researcher and women's health practitioner, is urging women to continue waging a battle against the Food and Drug Administration's (FDA) steps to limit their access to bioidentical hormones. Most recently, the FDA sent warning letters to several pharmacies that sell bioidentical hormones, saying that the claims these pharmacies make about the safety and effectiveness of bioidentical hormones are "unsupported by medical evidence, and are considered false and misleading...""I am very concerned that the FDA took this step. Limiting access to bioidenticals could create a potentially disastrous scenario for the millions of women in this country who have entered menopause and depend on hormone replacement therapy (HRT) for their health, comfort, and well-being," says Dr. Lark.

The research demonstrating the danger and side effects of conventional HRT is strong and convincing. The risk of life-threatening diseases such as breast cancer and heart attacks has been definitively shown to be much greater with conventional HRT. Many women also do not tolerate conventional HRT because of its numerous side effects. In contrast, bioidentical hormones have provided women with a much safer and effective option. There are far fewer health risks and side effects with bioidentical hormones.Dr. Lark urges women to call their state representatives or the FDA (1-888-463-6332) to relay their concerns and desires to keep bioidentical hormones readily available. It is crucial that women continue to have a choice in the management of their menopausal symptoms, and bioidentical hormones are the safest choice available.

Dr. Lark has devoted her career to raising awareness of women's health issues, such as PMS, obesity, hormone replacement therapy and osteoporosis. She pioneered the use of women's self-care treatments based on diet, nutrition, exercise and stress management, and has penned twelve books on women's health and healing. Her most recent title is Hormone Revolution.

Her monthly newsletter, Women's Wellness Today, and her web site, www.drlark.com, are dedicated to educating and empowering women to make the best choices for optimum health and beauty. Online visitors may sign up for Dr. Lark's free biweekly e-newsletter, which presents breaking health and beauty news along with lifestyle tips, easy recipes and simple exercises for health and beauty.

Healthy Directions, LLC is the recognized leader in providing authoritative health and beauty solutions to consumers. In addition to producing online resources and publishing newsletters, Healthy Directions, LLC encompasses its subsidiary, Doctors' Preferred, Inc. (DPI), a vitamin and nutritional supplement business that markets primarily through direct mail. Located in the Greater Washington, D.C., area, Healthy Directions, LLC (www.healthydirections.com) is a leading publisher in America. The company provides quality products and services for the health and beauty marketplaces.

###

Read the full story at http://www.prweb.com/releases/Dr-Lark/bioidentical_hormones/prweb1811184.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. PRA International Adds Dr. Susan Stansfield as Executive Vice President
2. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
3. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings
4. Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer
5. Celebrities Pledge to Wear Pink, End Breast Cancer Forever With Susan G. Komen for the Cure
6. PNY Technologies and Susan G. Komen for the Cure Partner to Raise Awareness of Breast Cancer
7. Susan G. Komen for the Cure Partners With the Original Butter Bell(R) Crock Developer
8. Susan G. Komen for the Cures Phoenix Affiliate, State Officials, Survivors and Advocates Call for Action on Breast Cancer
9. Susan G. Komen for the Cure Launches Unprecedented Global Expansion Program in 10 Countries
10. In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Dallas, TX (PRWEB) , ... December 07, 2016 ... ... service based in Dallas, Texas, is condemning "scam operations" carried out by unethical ... to bring these scam operations to a halt. According to Texas Premier Locksmith, ...
(Date:12/7/2016)... California (PRWEB) , ... December 07, 2016 , ... "ProBrand ... any and all media," said Christina Austin - CEO of Pixel Film Studios. , ... with easy to use drop zones. Editors can select from a variety of flip ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... and Wellness (IFW) Program at Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings ... a team of three acupuncturists to help patients realize their family building goals. ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Walking With God: Inspirational ... that will inspire the reader to be aware of God's direction in their lives. ... author, Sanford Smith, retired teacher and active church leader. , Sanford says, ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... Business Architecture Innovation Summit in Reston, VA on March 21-22, 2017. This premier ... a range of experiences from a cross-section of industries such as financial services, ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016  Arcturus Therapeutics, Inc. ... company, announced today that it entered into collaboration ... therapeutics for the treatment of NASH and other ... delivery platform LUNAR™ and UNA Oligomer chemistry. The ... Takeda,s long-standing commitment to and expertise in GI ...
(Date:12/6/2016)... Dec. 6, 2016  Regulus Therapeutics Inc. (NASDAQ: ... the discovery and development of innovative medicines targeting ... at its R&D day, held in ... is an anti-miR targeting microRNA-27 (miR-27) for the ... is an anti-miR targeting microRNA-17 (miR-17) for the ...
(Date:12/6/2016)... new study released today by the Alliance for Integrity ... Pricing Program will continue to expand at an unprecedented rate ... $23 billion in total purchases at the 340B price. This ... B drug reimbursement purchases over the next five years.      ... data on total drug purchases through 340B from 2005 to ...
Breaking Medicine Technology: